相关实验视频
Updated: Jun 17, 2025

07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
5.5K
与糖溶解相关的基因预测预后,并表明胃癌中的免疫微环境特征
Lu Xu1, Jin Liu2, Yuanqing An2
1Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
BMC cancer
|August 8, 2024
概括
糖解相关基因 (GRGs) 可以预测胃癌 (GC) 的预后和免疫微环境特征. 特定的GRG表达模式确定了患者亚型,并为胃癌的潜在治疗策略提供了信息.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 胃癌 (GC) 是全球癌症死亡的主要原因之一.
- 糖解是一种关键的代谢途径,对瘤微环境 (TME) 在癌症中的重编程至关重要.
- 了解糖解相关基因 (GRGs) 的作用对于预测GC结果和免疫特征至关重要.
研究的目的:
- 评估GRGs在胃癌中的预后和免疫调节功能.
- 根据GRG表达,识别出不同的GC分子亚型.
- 开发一种风险评分模型,用于预测胃癌患者生存率和免疫微环境特征.
主要方法:
- 利用TCGA-STAD和GEO数据集进行基因表达和临床数据分析.
- 确定了326个GRG,并进行了共识聚类来定义GC亚型.
- 开发了一种使用多变量考克斯回归的多基因预后风险评分模型.
- 使用CIBERSORT和ESTIMATE算法对免疫微环境进行评估.
- 进行了体外测试 (伤口愈合,透孔,MTT) 以调查基因功能.
主要成果:
- 确定了两种GC亚型:代谢性 (A组) 和免疫性 (B组),B组的预后较差.
- 一个六基因风险评分模型 (ME1,PLOD2,NUP50,CXCR4,SLC35A3,SRD35A3) 有效地预测了患者的结果.
- 低调CXCR4降低了GC细胞糖解,迁移,入侵和增殖.
- 尽管预后不佳,但高风险和免疫亚型显示出有利的免疫微环境和更高的免疫检查点基因表达.
- 高CXCR4和低ME1表达与CD8+T细胞透和增强的抗PD-1治疗反应相关.
结论:
- GRG表达特征可以预测胃癌的预后.
- 这些发现可能有助于临床决策和针对GC患者的个性化治疗策略.
- 这项研究强调了新陈代谢,免疫微环境和胃癌治疗反应之间的相互作用.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

